Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
11/2004
11/10/2004CN1174968C 1, 2 -bis -adducts of stable nitroxides with substituted ethylenes and stabilized compositions
11/09/2004US6815440 For therapy and prophylaxis of disorders in the course of which is involved an increased activity of matrix-degrading metalloproteinases
11/09/2004US6815205 Auxinic analogues of indole-3-acetic acid
11/09/2004US6815094 Diphenyl anthracene derivatives and organic electroluminescent device employing the same
11/09/2004US6815093 Light emitting materials based on indole skeleton
11/09/2004US6815031 Indolestyryl compounds and their uses in high-density recording media
11/09/2004CA2144344C Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents
11/04/2004WO2004094413A1 Phenacyl 2-hydroxy-3-diaminoalkanes
11/04/2004WO2004094378A1 Process for the preparation of carvedilol form-ii
11/04/2004WO2004094377A1 Method for separation of optically active dihydroxy- heptenoic acid esters
11/04/2004WO2004094376A1 Hydroxamic acids useful in the treatment of hyper-proliferative disorders
11/04/2004WO2004094372A2 Compounds useful as serine protease inhibitors
11/04/2004WO2004093789A2 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
11/04/2004WO2004080423A3 7-amino- isoindolyl compounds amd their pharmaceutical uses
11/04/2004WO2004080377A3 Kcnq channel modulating compounds and their pharmaceutical use
11/04/2004WO2004067703A3 5ht7 antagonists and inverse agonists
11/04/2004WO2004056769B1 Synthesis of amines and intermediates for the synthesis thereof
11/04/2004WO2004042351A3 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
11/04/2004WO2003103662A3 Inhibitors of glycoprotein vi
11/04/2004WO2003077847A3 Substituted amides
11/04/2004US20040220404 For therapy of obesity, diabetes, depression, or anxiety in a mammal
11/04/2004US20040220271 Fungicidal active compound combinations
11/04/2004US20040220253 Synthesis of pyrrole amides
11/04/2004US20040220252 Novel crystalline forms of trandolapril
11/04/2004US20040220248 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/04/2004US20040220237 Asthma and allergic inflammation modulators
11/04/2004US20040220236 4-Aryl quinols and analogs thereof as therapeutic agents
11/04/2004US20040220235 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/04/2004US20040220229 insulin resistance; central nervous system disorders; vision defects; anticholesterol agents;antilipemic agents; antiischemic agents
11/04/2004US20040220222 Malonamide derivatives
11/04/2004US20040220206 anticoagulants; antiinflammatory agents; cardiovascular disorders
11/04/2004US20040220202 antiinflammatory agents; central nervous system disorders; controlling cell proliferation, cell differentiation; anticancer agents; antidepressants
11/04/2004US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004US20040220183 inhibiting tumor necrosis factor; respiratory system disorders; prevent neutrophil infiltration in lungs; skin disorders
11/04/2004US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004US20040220169 anticoagulants; factor x inhibitor; N-[1-(5-chloro-1H-benzimidazol-2-yl)ethyl]-3-methyl-4-(2,5-dihydropyrrol-1-ylcarbonyl)benzamide
11/04/2004US20040220112 administering 2-(N-Methylsulfonamido-2-aminophenyl)-N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]acetamide as an anti-pruritic agent; antihyperalgesics; analgesics; central nervous system side effect reduction
11/04/2004US20040220108 Neo-tryptophan
11/04/2004US20040219446 Organophotoreceptors with azine-based compounds
11/04/2004DE10315654A1 8-Nitro-Tryptanthrin und andere Tryptanthrin-Derivate zur Therapie von Erkrankungen, die durch hoch-proliferierende Zellen verursacht werden 8-nitro-tryptanthrine and other tryptanthrine derivatives for the treatment of diseases caused by high-proliferating cells
11/04/2004CA2522805A1 Phenacyl 2-hydroxy-3-diaminoalkanes
11/04/2004CA2522565A1 Hydroxamic acids useful in the treatment of hyper-proliferative disorders
11/03/2004EP1473599A1 Organophotoreceptors with azine-based compounds
11/03/2004EP1473288A1 Nitric ester derivatives of COX-2 inhibitors and their use for treating inflammation and cardiovascular diseases
11/03/2004EP1472576A2 Sulfonate derivatives and the use therof as latent acids
11/03/2004EP1472246A1 Oxadiazoles having antiproliferative activity
11/03/2004EP1472228A1 Process for the manufacture of hmg-coa reductase inhibitors
11/03/2004EP1472226A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
11/03/2004EP1472221A2 Substituted indoles, method for production and use thereof for the inhibition of pain
11/03/2004EP1472216A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
11/03/2004EP1472215A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
11/03/2004EP1305278B1 Ruthenium complexes and their use in asymmetric hydrogenation
11/03/2004EP1206452B1 Novel method for preparing benzoperhydroisoindole compounds
11/03/2004EP0798292B1 Aniline derivatives having nitrogen monoxide synthase inhibitory activity
11/03/2004CN1543468A Processes for preparing calcium salt forms of statins
11/03/2004CN1543453A 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/03/2004CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
11/03/2004CN1174078C Organic electroluminescent element
11/03/2004CN1173991C Fik-1 as receiptor of growth factor of blood vessel inner-skin
11/03/2004CN1173973C Benzocarbazole and indenoindole derived estrogenic agents
11/03/2004CN1173947C 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
11/02/2004US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
11/02/2004US6812243 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation
11/02/2004US6812241 Nitrogen-containing heterocycles having parasiticidal properties
11/02/2004US6812237 (arylaminoaceamido)acetonitrile derivatives
11/02/2004CA2301787C New derivatives of benzo[3,4]cyclobuta[1,2-c]pyrrole, the procedure for preparing them and the pharmaceutical compounds that contain them
11/02/2004CA2115536C Heterocyclically substituted phenyl-cyclohexane-carboxylic acid derivatives
10/2004
10/28/2004WO2004092346A2 Small molecule inhibition of a pdz-domain interaction
10/28/2004WO2004092135A2 Substituted benzosulphonamide as potentiators of glutamate receptors
10/28/2004WO2004092134A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004WO2004092133A1 Novel method for the synthesis of (2s, 3as, 7as)-perhydroindole-2-carboxylic acid and the esters thereof and application thereof in the synthesis of perindopril
10/28/2004WO2004092132A1 [b]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004WO2004092131A1 Indole derivatives as ppar modulators
10/28/2004WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004WO2004092115A2 Hydroxamates as therapeutic agents
10/28/2004WO2004092095A1 Novel method for the synthesis of s-indoline-2- carboxylic acid and application thereof in the synthesis of perindopril
10/28/2004WO2004091482A2 M3 muscarinic acetylcholine receptor antagonists
10/28/2004WO2004082565A3 Asymmetric cyclization in the presence of substituted pseudophedrines
10/28/2004WO2004082357A3 Novel method for the synthesis of derivatives of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxylic acid and application thereof to the synthesis of perindopril
10/28/2004WO2004080422A3 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
10/28/2004WO2004048328A3 N-arylsulfonyl-3-aminoalkoxyindoles
10/28/2004WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/28/2004US20040215019 Substituted isoindoles and the e use thereof
10/28/2004US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis
10/28/2004US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004US20040214869 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
10/28/2004US20040214822 Substituted 4-aminocyclohexanol compounds
10/28/2004US20040214107 optical and electro-optical apparatus comprising recording layer consists of organic pigments and stabilizer agents, and reflection layers formed on light transmitting substrates; sensitivity for red light
10/28/2004US20040214040 Biphenyl derivatives and organic electroluminescent device employing the same
10/28/2004CA2527170A1 Therapeutic compounds
10/28/2004CA2522195A1 [b]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004CA2521364A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/27/2004EP1471064A1 Coumarin derivatives, process for their production and use thereof
10/27/2004EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
10/27/2004EP1470132A1 Polymerization catalyst system and its use in a polymerization process
10/27/2004EP1470107A2 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists
10/27/2004EP1470100A1 Triarylamine derivatives and the use thereof in organic electroluminescent and electrophotographic devices
10/27/2004EP1469851A1 Melanocortin receptor agonists